{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:14:48Z","timestamp":1791832488058,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.tim.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:26:49Z","timestamp":1679272009000},"page":"805-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines"],"prefix":"10.1016","volume":"31","author":[{"given":"Wearn-Xin","family":"Yee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Lavender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph M.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2023.02.011_bb0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2023.02.011_bb0010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"85","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2023.02.011_bb0015","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72822","article-title":"Reconstitution of surface lipoprotein translocation through the Slam translocon","volume":"11","author":"Huynh","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.tim.2023.02.011_bb0030","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tim.2023.02.011_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules","volume":"8","author":"Johnson","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2023.02.011_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The factor H protein family: the switchers of the complement alternative pathway","volume":"313","author":"Lucientes-Continente","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tim.2023.02.011_bb0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of C3b-factor H and implications for host protection by complement regulators","volume":"10","author":"Wu","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"Lewis","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.tim.2023.02.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900074","article-title":"How the membrane attack complex damages the bacterial cell envelope and kills gram-negative bacteria","volume":"41","author":"Doorduijn","year":"2019","journal-title":"BioEssays"},{"key":"10.1016\/j.tim.2023.02.011_bb0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04008","article-title":"Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility","volume":"3","author":"Caesar","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.tim.2023.02.011_bb0065","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jaci.2017.11.046","article-title":"The complement system in the airway epithelium: an overlooked host defense mechanism and therapeutic target?","volume":"141","author":"Kulkarni","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0070","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/eji.1830261017","article-title":"Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H","volume":"26","author":"K\u00fchn","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0075","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/bi201689j","article-title":"Structural and functional characterization of the product of disease-related factor H gene conversion","volume":"51","author":"Herbert","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.tim.2023.02.011_bb0080","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.20071069","article-title":"Structural basis for complement factor H-linked age-related macular degeneration","volume":"204","author":"Prosser","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2023.02.011_bb0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningococcal disease in patients with complement deficiencies: a case series (2008\u20132017)","volume":"19","author":"Ladhani","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/JB.01308-09","article-title":"Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter","volume":"192","author":"Oriente","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.tim.2023.02.011_bb0095","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1089\/ars.2017.7365","article-title":"Reassessing the structure and function relationship of the O2 sensing transcription factor FNR","volume":"29","author":"Mettert","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tim.2023.02.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100864","article-title":"Iron in infection and immunity","volume":"75","author":"Nairz","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.tim.2023.02.011_bb0105","first-page":"869","article-title":"The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes","volume":"158","author":"Sanders","year":"2012","journal-title":"Microbiology (N Y)"},{"key":"10.1016\/j.tim.2023.02.011_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12616","article-title":"Temperature triggers immune evasion by Neisseria meningitidis","volume":"502","author":"Loh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tim.2023.02.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005794","article-title":"Thermoregulation of meningococcal fHbp, an important virulence factor and vaccine antigen, is mediated by anti-ribosomal binding site sequences in the open reading frame","volume":"12","author":"Loh","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2023.02.011_bb0120","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000255","article-title":"Factor H binding protein (fHbp)-mediated differential complement resistance of a serogroup C Neisseria meningitidis isolate from cerebrospinal fluid of a patient with invasive meningococcal disease","volume":"3","author":"Facchetti","year":"2021","journal-title":"Access Microbiol."},{"key":"10.1016\/j.tim.2023.02.011_bb0125","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1073\/pnas.1521142113","article-title":"Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined","volume":"113","author":"Biagini","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2023.02.011_bb0130","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein","volume":"18","author":"Lucidarme","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197186","article-title":"Clustered intergenic region sequences as predictors of factor H binding protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines","volume":"13","author":"Cayrou","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2023.02.011_bb0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2023.02.011_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tim.2023.02.011_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.tim.2023.02.011_bb0155","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease\u2014population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2023.02.011_bb0160","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tim.2023.02.011_bb0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/INF.0000000000000823","article-title":"Confirmation of host genetic determinants in the CFH region and susceptibility to meningococcal disease in a central European study sample","volume":"34","author":"Biebl","year":"2015","journal-title":"J. Pediatr. Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0170","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1038\/srep35842","article-title":"Natural resistance to meningococcal disease related to CFH loci: Meta-analysis of genome-wide association studies","volume":"6","author":"Martin\u00f3n-Torres","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2023.02.011_bb0175","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2023.02.011_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660194","article-title":"A family affair: addressing the challenges of factor H and the related proteins","volume":"12","author":"Poppelaars","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0185","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2023.02.011_bb0190","first-page":"4155","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony","year":"2009","journal-title":"Microbiology (N Y)"},{"key":"10.1016\/j.tim.2023.02.011_bb0195","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.ajhg.2022.08.001","article-title":"Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations","volume":"109","author":"Kumar","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tim.2023.02.011_bb0200","first-page":"2080","article-title":"Copy number variation in the complement factor H-related genes and age-related macular degeneration","volume":"17","author":"Kubista","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.tim.2023.02.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2023.02.011_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/20477724.2016.1274068","article-title":"Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa","volume":"111","author":"Mohammed","year":"2017","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.tim.2023.02.011_bb0215","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1093\/infdis\/jiz279","article-title":"Toward a global genomic epidemiology of meningococcal disease","volume":"220","author":"Retchless","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S1473-3099(15)00267-4","article-title":"Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study","volume":"15","author":"Hill","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0225","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(20)30842-2","article-title":"Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1\u20134 cross-sectional survey results","volume":"21","author":"MacLennan","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2018.23.20.17-00474","article-title":"Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year","volume":"23","author":"Bratcher","year":"2018","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.tim.2023.02.011_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009992","article-title":"Genome-wide association studies reveal the role of polymorphisms affecting factor H binding protein expression in host invasion by Neisseria meningitidis","volume":"17","author":"Earle","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2023.02.011_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009461","article-title":"Deconvolution of intergenic polymorphisms determining high expression of factor H binding protein in meningococcus and their association with invasive disease","volume":"17","author":"Spinsanti","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2023.02.011_bb0245","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","article-title":"Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0250","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2023.02.011_bb0255","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jinf.2020.07.034","article-title":"Methods to evaluate serogroup B meningococcal vaccines: from predictions to real-world evidence","volume":"81","author":"Borrow","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.tim.2023.02.011_bb0260","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2023.02.011_bb0265","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"Seib","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2023.02.011_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(22)00424-8","article-title":"Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies","volume":"23","author":"Marshall","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2023.02.011_bb0275","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.vaccine.2022.01.046","article-title":"Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older","volume":"40","author":"Beeslaar","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2023.02.011_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.2020043","article-title":"Product review on the IMD serogroup B vaccine Bexsero\u00ae","volume":"18","author":"Deghmane","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.tim.2023.02.011_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tim.2023.02.011_bb0290","doi-asserted-by":"crossref","first-page":"14823","DOI":"10.1073\/pnas.1507829112","article-title":"A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes","volume":"112","author":"Konar","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2023.02.011_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.tim.2023.02.011_bb0300","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88907","article-title":"Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding","volume":"1","author":"Granoff","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.tim.2023.02.011_bb0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2017.12.045","article-title":"Development of an FHbp-CTB holotoxin-like chimera and the elicitation of bactericidal antibodies against serogroup B Neisseria meningitidis","volume":"36","author":"Price","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2023.02.011_bb0310","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1038\/s41598-019-43139-0","article-title":"Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis","volume":"9","author":"Awanye","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2023.02.011_bb0315","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tim.2023.02.011_bb0320","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-018-03146-7","article-title":"Structure-based design of chimeric antigens for multivalent protein vaccines","volume":"9","author":"Hollingshead","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2023.02.011_bb0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2023.02.011_bb0330","doi-asserted-by":"crossref","first-page":"e00305","DOI":"10.1128\/IAI.00305-17","article-title":"Neisseria cinerea expresses a functional factor H binding protein which is recognized by immune responses elicited by meningococcal vaccines","volume":"85","author":"Lavender","year":"2017","journal-title":"Infect. Immun."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X23000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X23000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:48:42Z","timestamp":1760813322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X23000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0966842X23000598"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2023.02.011","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}